These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24563280)

  • 1. The association of Crk-like adapter protein with poor prognosis in glioma patients.
    Yao C; Lv S; Han M; Zhang J; Zhang Y; Zhang L; Yi R; Zhuang D; Wu J
    Tumour Biol; 2014 Jun; 35(6):5695-700. PubMed ID: 24563280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
    Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
    Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
    Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
    J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
    Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
    Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin is a new potential prognostic biomarker for glioma.
    Tian B; Zhang Y; Zhang J
    Tumour Biol; 2014 Jun; 35(6):5877-83. PubMed ID: 24719188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of Sema3C is associated with glioma malignancy.
    Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
    Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of FOXP3 expression in human gliomas.
    Wang L; Zhang B; Xu X; Zhang S; Yan X; Kong F; Feng X; Wang J
    Clin Transl Oncol; 2014 Jan; 16(1):36-43. PubMed ID: 23579918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIZ1: a potential tumor suppressor in glioma.
    Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
    BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.
    Xu Y; Yuan J; Zhang Z; Lin L; Xu S
    Mol Biol Rep; 2012 Sep; 39(9):8979-85. PubMed ID: 22714920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of pathology and survival by FDG PET in gliomas.
    Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
    J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
    Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
    Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
    Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
    Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
    Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
    Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of cyclin D1 in brain gliomas and its significance].
    Tan PG; Xing Z; Li ZQ
    Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression level of human miR-34a correlates with glioma grade and prognosis.
    Gao H; Zhao H; Xiang W
    J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.
    Abou-Ghazal M; Yang DS; Qiao W; Reina-Ortiz C; Wei J; Kong LY; Fuller GN; Hiraoka N; Priebe W; Sawaya R; Heimberger AB
    Clin Cancer Res; 2008 Dec; 14(24):8228-35. PubMed ID: 19088040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.
    Wang L; Qin H; Li L; Zhang Y; Tu Y; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    Med Oncol; 2012 Dec; 29(5):3491-7. PubMed ID: 22926920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PinX1 is up-regulated and associated with poor patients' survival in gliomas.
    Bai J; Chen YS; Mei PJ; Liu QH; Du Y; Zheng JN
    Int J Clin Exp Pathol; 2015; 8(6):6952-9. PubMed ID: 26261583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma.
    Liu H; Li G; Zeng W; Zhang P; Fan F; Tu Y; Zhang Y
    Med Oncol; 2014 Aug; 31(8):77. PubMed ID: 24998422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.